INmune Bio enters new employment agreements with CEO, CFO, and CSO

Inmune Bio, Inc.

CEO David Moss: $500,000 base salary, 50% bonus target, option for 800,000 shares.
CFO Cory Ellspermann: $275,000 base salary, 40% bonus target, option for 300,000 shares.
CSO Mark Lowdell: £300,000 base salary, up to 20% annual bonus, 18-month severance.
Severance for Moss/Ellspermann: 18 months base salary, prorated bonus, and COBRA payments.
New agreements effective November 1, 2025; all include change-of-control equity acceleration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.